NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · LARGE CAP
LivaNova PLC LIVN
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.4B
▲ 10.7% vs FY2024
EPS · FY25
$-4.45
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-19.2%
Net margin · FY25
-17.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.4B
Revenue, FY2025 · full 12-year series below
Revenue
Net income
The company lost 17 cents on every revenue dollar this year.
Per share
USD -4.45
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-19.2%
Return on equity, FY2025
ROE
Operating margin14.4%
Net margin-17.5%
Return on assets-9.5%
Each USD of equity lost 19 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+8.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.8%
+8.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years+12.3%
Change, 10 years—
The share count grew 12% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.6B
total assets, end of FY2025
Total assetsUSD 2.6B
EquityUSD 1.2B
CashUSD 635.6M
Gross debtUSD 376.1M
Net debtUSD -259.5M
Current ratio1.36×
The company holds more cash than debt.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
Revenue $B
1.4
1.3
1.2
1.0
1.0
0.9
1.1
1.1
1.0
1.0
0.3
0.3
Operating income $B
0.2
0.1
−0.1
−0.1
−0.0
−0.3
−0.2
−0.2
0.1
0.0
0.1
0.1
EBITDA $B
0.2
0.2
−0.0
−0.1
0.0
−0.2
−0.1
−0.2
0.1
0.1
0.1
0.1
Income tax $B
0.0
0.0
−0.1
0.0
0.0
−0.0
−0.0
−0.1
0.0
0.0
0.0
0.0
Net income $B
−0.2
0.1
0.0
−0.1
−0.1
−0.3
−0.2
−0.2
−0.0
−0.1
0.1
0.1
EPS, diluted $
−4.45
1.16
0.32
−1.61
−2.68
−7.18
−3.26
−3.91
−0.52
−1.28
2.17
2.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−19.2
4.9
1.4
−6.9
−11.3
−28.0
−11.0
−11.4
−1.4
−3.7
21.6
21.2
Shares out B
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
48.03
0.03
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
43 of 45
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 2 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed